Cell Reports (Sep 2023)

Mast cell deficiency improves cognition and enhances disease-associated microglia in 5XFAD mice

  • Chih-Chung Jerry Lin,
  • Fanny Herisson,
  • Hoang Le,
  • Nader Jaafar,
  • Kashish Chetal,
  • Mary K. Oram,
  • Kelly L. Flynn,
  • Evan P. Gavrilles,
  • Ruslan I. Sadreyev,
  • Felipe L. Schiffino,
  • Rudolph E. Tanzi

Journal volume & issue
Vol. 42, no. 9
p. 113141

Abstract

Read online

Summary: Emerging evidence suggests that peripheral immune cells contribute to Alzheimer’s disease (AD) neuropathogenesis. Among these, mast cells are known for their functions in allergic reactions and neuroinflammation; however, little is known about their role in AD. Here, we crossed 5XFAD mice with mast cell-deficient strains and observed the effects on AD-related neuropathology and cognitive impairment. We found that mast cell depletion improved contextual fear conditioning in 5XFAD mice without affecting cued fear conditioning, anxiety-like behavior, or amyloid burden. Furthermore, mast cell depletion led to an upregulation of transcriptomic signatures for putatively protective disease-associated microglia and resulted in reduced markers indicative of reactive astrocytes. We hypothesize a system of bidirectional communication between dural mast cells and the brain, where mast cells respond to signals from the brain environment by expressing immune-regulatory mediators, impacting cognition and glial cell function. These findings highlight mast cells as potential therapeutic targets for AD.

Keywords